Oral and subcutaneous
The Efficacy of Subcutaneous Versus Oral Methotrexate in Patients with Juvenile Idiopathic Arthritis
... When improvement of different core set variables according to ACR-30 were analysed individually, improvement of active arthritis was highest (90% in Group B and 85% in Group A). Minimum improvement was found in the ...
5
Methotrexate and Rheumatoid Arthritis : Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
... of oral and subcutaneous MTX usage in ...methotrexate, subcutaneous route, oral route, rheumatoid arthritis, treatment, pharmacokinetic, efficacy and toxicity were used (Table ...
10
The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
... Compare oral immunotherapy (OIT) and subcutaneous immunotherapy (SCIT) in murine models for CMA and PNA and determine the dose of allergen needed to effectively modify parameters of ...
13
Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
... The aim of this study is to identify suboptimal patient experience with MTX and to raise awareness for clinicians to identify opportunities to mitigate bothersome symptoms and side effects and optimize response to MTX. ...
11
A Randomized Controlled Study Comparing Subcutaneous Pethidine with Oral Diclofenac forPain Relief after Caesarean Section
... regular oral diclofenac as postoperative analgesia was evaluated in a randomized controlled study and it was compared to the established method of parenteral ...of oral diclofenac twice daily or 1 mg/kg of ...
7
The relative plasma availabilities of ivermectin in reindeer (Rangifer tarandus tarandus) following subcutaneous and two different oral formulation applications
... Discussion The maximum ivermectin plasma concentrations mea- sured in the subcutaneously injected reindeer were higher in this study than in a previous one with similar animals [9]. In that earlier experiment, no ...
7
Acute and chronic metabolic responses of transition dairy cows with fatty liver disease to subcutaneous glucagon injections, oral glycerol, or both
... to Subcutaneous Glucagon Injections, Oral Glycerol, or ...to Subcutaneous Glucagon Injections, Oral Glycerol, or ...or oral glycerol alone in rapid alleviation of energy status-related ...
122
Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans
... mg subcutaneous (SC) sumatriptan to treat migraine and the relationship between response of migraine and cutaneous allodynia in a population of migraine patients who historical- ly failed to respond to oral ...
6
Porcine adipose-derived stem cells from buccal fat pad and subcutaneous adipose tissue for future preclinical studies in oral surgery
... Conclusions Our data suggest that the buccal fat pad might be a novel source of MSCs. This region contains a population of pro- genitor cells with stemness features that are able to differ- entiate in vitro and also are ...
11
Oral Administration Following Subcutaneous Administration of FCV Vaccines Enhances Vaccine Efficacy against Challenge of a Highly Virulent Vs Feline Calicivirus
... initial subcutaneous vaccination followed by subcutaneous boosts on day 21 (SC/SC); or an initial subcutaneous vaccination followed by one oral (sublingual) booster immunization on day 21 ...
7
Does continuous subcutaneous hydrocortisone infusion therapy improve vitality in adult patients with Addison’s Disease when compared to oral hydrocortisone therapy?
... were oral hydrocortisone therapy and continuous subcutaneous hydrocortisone infusion ...continuous subcutaneous hydrocortisone infusion therapy, and did not study patients’ vitality scores before and ...
14
Diabetes Use of subcutaneous insulin and oral hypoglycaemics in the Maternity Unit (GL943)
... • Most women, who are not on intravenous insulin, self-administer subcutaneous doses. • To protect the woman and the midwives looking after her, the Trust has a Self- administration of Insulin Policy, which must ...
9
Continuous Subcutaneous Hydrocortisone Infusion versus Oral Hydrocortisone Replacement for Treatment of Addison’s Disease: A Randomized Clinical Trial
... modified-release oral therapies and the current CSHI dosing schedule may create a smooth circadian cortisol profile, but the normal biorhythm also includes an ultradian rhythm superimposed on the circa- dian ...
10
Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review
... The National Library of Medicine's computerized biblio- graphic database (Medline 1966 to December 1999) was searched using a combination of the following keywords: thalassemia, serum ferritin, urinary iron excretion, ...
9
A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS
... b. Patients who may benefit from this type of therapy include those who are nauseated and vomiting, experiencing dysphasia, delirium, confusion, stupor or other changes in mental status, last days or hours of life, ...
6
Abdominal Superficial Subcutaneous Fat
... ANOVA linear test was used to evaluate the characteristics of the study popula- tion across SSAT tertiles. We performed multivariate linear regression models, ad- justed for age and waist circumference, to evaluate ...
9
Subcutaneous Medication Administration Practices of Staff Nurses
... Content validity of the tool was made and necessary modifications were made according to the expert’s opinion and tool was finalized. The inter-rater reliability was done for observational checklist for oral route ...
6
Subcutaneous Emphysema Is Iatrogenic Complication in Dental Surgery
... Two determining factors are always involved with subcutaneous emphysema. On the one hand, a compressed air procedure (air turbine handpiece, air-water syringe), and on the other, a communication between the ...
9
Guidelines for the Use of Subcutaneous Medications in Palliative Care
... For drug combinations, it is important to check for stability information. When should the CSCI be started? If the patient is in pain and not currently on a modified or slow release opioid, e.g. MST ¨ or Oxycontin, the ...
30
Subcutaneous Immunotherapy in Patients with Fagales Pollen Induced Oral Allergy Syndrome
... subjective judgment rather than a more objective measure- ment by double blind placebo controlled oral food challenge test. The small number of enrolled patients that received SCIT did not provide much statistical ...
6